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The role of the 5' noncoding region of the herpes simplex virus type 1 glycoprotein C (gC) gene in viral gene
expression was investigated with recombinant herpesviruses that contained the bacterial 13-galactosidase gene
under the control of the gC promoter-regulatory region. Each of these viruses had the same DNA sequences
from the start of gC transcription upstream to -114 but had variable segments of the downstream
140-base-pair sequence that is between the start of gC transcription and translation. Analysis of 13-galactosidase
expression and mRNA synthesis from these viruses demonstrated the importance of DNA sequences from the
start of gC transcription downstream to +38 for optimal expression from the gC promoter.
To define the DNA sequences that are involved in regu-
lation and expression of viral late genes, we have con-
structed recombinant herpesviruses that express the bacte-
rial enzyme 1-galactosidase (13-Gal) from the promoter of the
glycoprotein C (gC) gene, a well-characterized herpesvirus
late gene. Recombinant viruses are advantageous in the
study of late promoter-regulatory regions because herpesvi-
rus late genes that are removed from the viral genome no
longer require viral DNA replication for their expression (3,
9, 11, 12). In previous studies using recombinant viruses, we
demonstrated that sequences between -1350 and +30 rela-
tive to the start of gC transcription regulate 13-Gal as a viral
late gene and that upstream sequences can be deleted to at
least -109 without affecting expression (14). Other studies
(5, 6) have shown that upstream gC sequences can be deleted
to -34 without affecting expression and that a 15-base-pair
(bp) TATA box promoter element is absolutely required for
gC expression.
Although gC sequences between -109 and +30 regulate
13-Gal expression as a late viral gene in recombinant viruses,
it is not clear whether gC sequences downstream from +30
have a role in gC expression. Homa et al. (5) noticed that
deletions ofDNA segments containing the start of transcrip-
tion and downstream sequences lower the relative level of
gC mRNA, and they suggested that this was due to a
shortening in the length of the nontranslated leader that is
non-sequence specific. In this report, we describe the con-
struction of a set of recombinant herpesviruses designed to
determine whether sequences involved in the regulation of
herpes simplex virus type 1 (HSV-1) gC expression are
located in the 5' untranslated region of the gene. Each of
these recombinant viruses had the p-Gal gene under the
control of the promoter for the late viral gC gene. Each gC
promoter contained sequences from the start of transcription
upstream to -114 but different segments of the downstream
140-bp nontranslated sequence between the start of tran-
scription and translation.
The DNA sequences of the gC gene containing the 5'
nontranslated leader of the gene were isolated by insertion of
a unique SaI restriction enzyme site in the cloned gC gene at
position + 141 relative to the start of transcription. This
changed the ATGGCC that begins the gC coding sequence
* Corresponding author.
(4) to GTCGAC but left the 140 bp between the start of gC
transcription and translation unaltered. Promoter sequences
of the gC gene from -114 to + 140 were inserted upstream of
the ,B-Gal gene in the HSV-1 insertion vector pGal8 (J. P.
Weir, K. R. Steffy, and M. Sethna, submitted for publica-
tion) to generate the plasmid pgCL1. In addition to the gC
sequences upstream of the 1-Gal gene, gCL1 contained an
additional 35 bp from the Sall site to the ATG that begins
1-Gal translation (Fig. 1). The construction gCL3 contained
the same gC promoter sequences, -114 to +140, upstream
of the ,B-Gal gene as gCL1, but the 35 bp between the gC
promoter and the ATG that begins 1-Gal translation was
eliminated. Thus, the coding sequences for ,B-Gal began at
+ 141, in the same position in which the coding sequences for
gC are normally located in the authentic gC gene. Sequential
3'-to-5' deletions were made in the gC leader region that left
sequences to +71 (gCL5), +38 (gCL6), +16 (gCL6.1), and
-3 (gCL7). Two other constructions with deleted sequences
between +28 and +99 (gCL3.1) and +2 and +39 (gCL8)
were made. Recombinant viruses were made from each
plasmid construction as described previously (14).
When Vero cells were infected with each of the recombi-
nant viruses in the presence or absence of phosphonoacetic
acid (PAA), an inhibitor of viral DNA replication, all of the
viruses that expressed ,B-Gal did so in the manner of a late
viral gene. Expression was first detectable at approximately
6 h after infection and continued to rise for at least 24 h (data
not shown). Figure 1 shows the expression of 1-Gal at 24 h
postinfection in the presence and absence of PAA. Elimina-
tion of the 35 bp between the gC leader sequences and the
ATG that begins the 1-Gal open reading frame (Fig. 1)
resulted in a higher level of ,B-Gal expression in vgCL3- than
in vgCL1-infected cells. Since the location of the 13-Gal open
reading frame has perfectly replaced the gC open reading
frame in vgCL3, the p-Gal activity of vgCL3-infected cells
was set at 100%. Although the lower level of ,B-Gal expres-
sion in vgCL1-infected cells could be due to the addition of
non-gC sequences, we think that a more likely explanation is
that the sequence around the ATG in vgCL1 contains a
pyrimidine at -3 relative to the A of the ATG. Such a
sequence is not predicted to be as favorable for translation as
the sequence that exists if a purine is present at this position
(7). In each of our other constructions, the sequences
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FIG. 1. Construction of HSV-1 recombinant viruses and expression of p-Gal. A 2,000-bp SaiI-EcoRI fragment of HSV-1 (KOS) DNA
containing the first 500 bp of the coding sequence for gC and approximately 1,500 bp upstream from the start of gC translation was cloned
into the phagemid vector Bluescribe M13+ (Stratagene). A SalI restriction site was generated by oligonucleotide mutagenesis (8) at +141
relative to the start of transcription. A HindIlI site was inserted by mutagenesis at -118 (leaving gC promoter sequences unchanged to -114),
and the gC sequences from -114 to +141 were cloned into the HSV-1 insertion vector pGal8. This insertion vector has the coding sequences
of the Escherichia coli p-Gal gene flanked by sequences from the HSV-1 thymidine kinase gene to direct homologous recombination into the
thymidine kinase gene of the viral genome. Recombinant viruses were isolated as described previously (14). The promoter sequences from
gCL1 were recloned into the phage vector M13mpl8, and the indicated deletions were made by oligonucleotide mutagenesis with
oligonucleotides that spanned the desired deletion. After mutagenesis, the promoter sequences were recloned into pGal8 for insertion into the
viral genome. The additional 35-bp segment of DNA present in gCL1 between the gC leader and the p-Gal coding sequence (U) is from the
original fragment of DNA that contained the P-Gal gene used to construct pGal8. Vero cells were infected at a multiplicity of infection of 10
in the presence or absence of 300 ,ug of PAA per ml with each of the recombinant viruses. The p-Gal activity was measured at 24 h
postinfection as described previously (14) and expressed relative to that of vgCL3.
brought adjacent to the ATG are predicted to be favorable
for translation.
Progressive deletions from the start of translation toward
the start of transcription resulted in decreasing levels of
p-Gal expression (Fig. 1). Deletion of sequences to +38
(vgCL6) reduced p-Gal expression to 70% of that exhibited
by vgCL3. Deletion of another 22 bp to +16 (vgCL6.1)
resulted in a more dramatic reduction of expression to 26%
of maximal expression, and elimination of the entire 140-bp
leader and mRNA start site (vgCL7) abolished detectable
p-Gal expression. None of these viruses expressed detect-
able p-Gal when viral DNA replication was inhibited with
PAA, indicating that elimination of gC leader sequences did
not affect temporal regulation.
A progressive decrease in observed p-Gal expression
could be due to the elimination of the specific DNA se-
quences that are important for expression or to a progressive
reduction in the length of the gC leader that is non-sequence
specific. Two deletions, gCL3.1 and gCL8, were constructed
to address this question. In vgCL3.1, 70 bp of the gC leader
sequence between +28 and +99 was eliminated, with a
resulting reduction of p-Gal expression to 25%. Elimination
of 36 bp of the gC leader sequence in vgCL8 (sequences
between +2 and +39) reduced p-Gal expression in infected
J. VIROL.
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FIG. 2. Analysis of the 5' ends of p-Gal mRNAs. Vero cells were infected with recombinant viruses at a multiplicity of infection of 10,
and total RNA was isolated 24 h later. After hybridization with a 5'-end-labeled oligonucleotide complementary to the 5' end of the p-Gal
gene, primer-RNA hybrids were extended with reverse transcriptase (14). The extended products (lanes PE) were separated on a 6%
sequencing gel alongside a sequence ladder prepared with the same primer and the corresponding plasmid DNA. (A) Primer extension analysis
ofRNA from vgCL3-infected cells; (B) RNA from vgCL6.1-infected cells; (C) RNA from vgCL8-infected cells; (D) RNA from cells infected
with vgCL7 in the presence (lane PE2) or absence (lane PE1) of PAA. The short sequence shown is that of the coding strand around the start
of transcription.
cells to 31% of maximal expression. The remaining leader
sequence in vgCL3.1 and vgCL8 is substantially longer than
that remaining in vgCL5 and vgCL6, yet the levels of p-Gal
expression are dramatically lower. The results obtained with
vgCL3.1 and vgCL8 indicate that the elimination of gC
leader sequences upstream of +39 had a much more dra-
matic effect on expression than the actual length of the gC
leader sequence did.
In order to determine whether deletions in the 5' nontrans-
lated region of gC that resulted in lower levels of P-Gal
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FIG. 3. Accumulation of p-Gal mRNA in cells infected with
vgCL3 (lanes 3) and vgCL8 (lanes 8). (A) RNAs (40 ,ug) from vgCL3-
and vgCL8-infected cells were analyzed for the presence of p-Gal
mRNA by Northern blotting. Nitrocellulose membranes were hy-
bridized to a 32P-labeled p-Gal-specific DNA probe, washed, and
subjected to autoradiography. The relative amounts of p-Gal mRNA
were determined by densitometry of the autoradiographs. Labeled
DNA markers (lane M) were denatured in the same way as the RNA
and were run on the gel for comparison. Sizes shown are in kilobase
pairs. The relative p-Gal mRNA ratio (vgCL8/vgCL3) was 0.30. (B)
Primer extension analysis of p-Gal mRNAs from vgCL3- and
vgCL8-infected cells was as described in the legend to Fig. 2. The
sequence ladder was generated from the p-Gal primer and pgCL8
DNA. The relative amounts of p-Gal primer extension products
were determined by densitometry of the autoradiograph. The
amount of gC mRNA was quantitated in each sample to serve as an
internal control for the amount of RNA used in each assay. The
relative p-Gal mRNA ratio (vgCL8/vgCL3) was 0.38.
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FIG. 4. Stability of P-Gal mRNA in cells infected with vgCL3 (A) and vgCL8 (B). Vero cells (1 x 10') were infected with recombinant
virus at a multiplicity of infection of 10. At 12 h postinfection, dactinomycin (actinomycin D) was added to a final concentration of 10 jig/ml.
RNA was isolated 3, 6, and 12 h later and used for primer extension analysis (lanes 3, 6, and 12, respectively). The relative amounts of p-Gal
primer extension products were determined by densitometry of autoradiographs.
recombinant virus that expressed p-Gal retained the original
mRNA start site, regardless of the level of p-Gal expression.
Because the start of p-Gal translation in vgCL7 was
positioned upstream from the normal start of gC transcrip-
tion, the lack of p-Gal expression did not necessarily reflect
the lack of mRNA expression from the -114 to -3 gC
promoter sequences. The lack of p-Gal expression might be
due to the inability of an expressed mRNA to translate a
functional p-Gal protein. To address this possibility, RNA
was also isolated from vgCL7-infected cells in the presence
or absence of PAA and was analyzed by primer extension
(Fig. 2D). A faint primer extension product was observed to
migrate alongside the G residue (coding strand) at -3 (lane
PE1). However, neither the major extension product nor the
other minor extension products were observed. Further-
more, in the presence of PAA, no primer extension products
were seen (lane PE2). Therefore, deletion of the entire gC
leader region and normal mRNA start site eliminated mRNA
synthesis from the major gC start site.
The reduced p-Gal expression that resulted from deletions
in the gC noncoding leader could be the result of a decrease
in the level of p-Gal mRNA or a decrease in translation of
p-Gal mRNA. To evaluate these two possibilities, RNA was
isolated from cells infected with either vgCL3 or vgCL8 and
analyzed by Northern (RNA) blot hybridization. RNA from
infected cells was probed initially for gC mRNA with a
32P-labeled DNA fragment specific for gC. The size of the
major RNA species detected by the gC probe was approxi-
mately 2.5 kilobases (data not shown), which corresponded
to the size previously reported for the gC mRNA (4). The
amount ofgC mRNA was quantitated by densitometry of the
autoradiographs to serve as an internal control for the
amount of RNA loaded onto each well of the gel. The gC
probe was then removed, and the membrane was probed
with a second 32P-labeled fragment that was specific for
P-Gal. The size of the major RNA species detected by the
p-Gal probe was approximately 4.3 kilobases (Fig. 3A),
which corresponded to the size expected for the p-Gal
transcript. The relative amounts of p-Gal mRNA in vgCL8-
and vgCL3-infected cells were quantitated by densitometry
of the autoradiographs.
The accumulation of p-Gal mRNA in vgCL8- and vgCL3-
infected cells was also determined by primer extension (Fig.
3B). After autoradiography of the sequencing gel with the
p-Gal primer extension products ofvgCL8 and vgCL3 RNA,
the relative amounts of p-Gal mRNA were again quantitated
by densitometry. The relative steady-state levels of p-Gal
mRNA produced in vgCL3- and vgCL8-infected cells re-
flected the relative p-Gal activity observed (Fig. 1 and 3).
The decrease in p-Gal mRNA accumulation that resulted
from the deletion of sequences between +2 and +39 could
be due to either a decrease in the rate ofmRNA synthesis or
a decrease in mRNA stability. To determine the relative
stability of the p-Gal mRNA in vgCL3- and vgCL8-infected
cells, RNA was isolated 3, 6, and 12 h after the addition of
dactinomycin and quantitated by primer extension. The level
of p-Gal mRNA in vgCL3- and vgCL8-infected cells gradu-
ally diminished in the 12 h after dactinomycin addition, with
an estimated half-life of p-Gal mRNA of >10 h (Fig. 4). For
comparison, the relative stability of gC mRNA was deter-
mined by primer extension analysis with the same RNAs. In
both vgCL3- and vgCL8-infected cells, gC mRNA decayed
J. VIROL.
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at similar rates with an estimated half-life similar to that of
p-Gal mRNA (data not shown). Thus, the decrease in
relative ,-Gal mRNA levels in vgCL8- and vgCL3-infected
cells cannot be accounted for by a decrease in mRNA
stability. Although these results suggest that sequences
between +2 and +39 are important for mRNA synthesis,
this has not been shown directly. Unfortunately, results
from direct measurement of HSV-1 initiation at late times
during infection are difficult to interpret (13).
Although the results from recombinant virus construction
show the importance of gC leader sequences upstream from
+39, the actual role of these sequences in gene expression
remains to be resolved. A recent report showed that the
immediate-early 175-kilodalton protein (a4) of HSV-1 binds
to DNA fragments derived from the 5' noncoding leader
region of two viral late genes (10). It remains to be deter-
mined whether the gC leader sequences determined here to
be important for gC expression will also bind a4. Inspection
of the leader sequences of the three genes did not reveal any
obvious similarities.
Other reports have indicated a role for the 5' leader
regions in the expression of HSV-1 genes other than gC.
Using transient assays, Blair et al. (1) showed that sequences
from -3 to +77 in the leader region of the viral gene VP16
are necessary for virus-induced transcription. Coen et al. (2)
observed that a mutation in the +5-to-+15 region of the
thymidine kinase gene, when introduced into the viral ge-
nome, significantly lowered thymidine kinase mRNA accu-
mulation and transcription rate. Further studies, including
mutational analyses, of the 5' nontranslated region of imme-
diate-early, early, and late HSV-1 genes should lead to a
better understanding of the role of this part of the gene in
viral gene expression and regulation.
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